SUNPHARMA

will present 14 abstracts at the 2026 AAD Meeting highlighting positive clinical data for ILUMYA in nail psoriasis, LEQSELVI in severe alopecia areata, and WINLEVI in acne treatment. Results demonstrate sustained efficacy and rapid hair regrowth, reinforcing the company's specialty dermatology and immunology portfolio.